Mechanisms of osteolytic bone destruction

Bone

Volumn 12, Issue SUPPL. 1, 1991, Pages

  Mundy, G R ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Bone resorption; Cytokines; Osteolytic bone disease; Parathyroid hormone related protein; Skeletal metastasis; Transforming growth factors

Indexed keywords

PARATHYROID HORMONE DERIVATIVE;

BONE DESTRUCTION; BONE METASTASIS; ETIOLOGY; HUMAN; MYELOMA; OSTEOLYSIS; REVIEW;

BONE NEOPLASMS; BONE RESORPTION; HUMAN; HYPERCALCEMIA; LYMPHOMA; MULTIPLE MYELOMA; NEOPLASM CIRCULATING CELLS; NEOPLASM PROTEINS; NEOPLASMS; OSTEOBLASTS; OSTEOCLASTS; OSTEOLYSIS; PROTEINS; SUPPORT, U.S. GOV'T, P.H.S.; TRANSFORMING GROWTH FACTORS;

EID: 0025850907     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/8756-3282(91)90057-P     Document Type: Article

References (71)

1. Serum levels of interleukin-6, a potent myeloma cell growth factor, as a reflection of disease severity in plasma cell dyscrasias
2. Breast cancer, prostaglandins, and bone metastases
3. Interleukin-6 causes hypercalcaemia in vivo, and enhances the bone resorbing potency of interleukin-1 and tumor necrosis factor by two orders of magnitude in vitro
4. Scanning electron microscopy in bone pathology: Review of methods, potential and application
5. Scanning electron microscopy in bone pathology: Review of methods. Potential and applications
6. Hypercalcaemia associated with increased serum calcitriol levels in three patients with lymphoma
7. 1
8. Transforming growth factor beta inhibits formation of osteoclast-like cells in long-term human marrow cultures
9. 3 and activity on human osteoblast-like cells in short term cultures
10. Production of interleukin-1 by bone marrow myeloma cells
11. Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors
12. Direct resorption of bone by human breast cancer cells in vitro
13. Mechanisms of bone destruction in the development of skeletal metastases
14. Relationship of bone destruction in skeletal metastases to osteoclast activation and prostaglandins
15. Interactions between interleukin-6 and interleukin-1 in osteoclastic bone resorption in neonatal mouse calvariae
16. Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo
17. Production of the bone resorbing cytokine lymphotoxin by cultured human myeloma cells
18. Osteolytic steroid in human breast cancer
19. Circulating phytosterols in normal females, lactating mothers, and breast cancer patients
20. Existence of parathyroid hormone binding sites on murine hemopoietic blast cells
21. Growth factors in bone matrix
22. Similarity of synthetic peptide from human tumor to parathyroid hormone in vivo and in vitro
23. Effects of human transforming growth factor (TGF) alpha on bone resorption and formation in vitro
24. Stimulation of bone resorption in vitro by synthetic transforming growth factor alpha
25. Prostatic osteoblastic factor
26. Interleukin-1 accelerates autocrine growth of myeloma cells through interleukin-6 in human myeloma
27. Parathyroid hormone-related protein of malignancy: active synthetic fragments
28. Prostaglandins: stimulation of bone resorption in tissue culture
29. Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells
30. Characteristics of prostate-derived growth factors for cells of the osteoblast phenotype
31. Identification of a pure population of committed osteoclast precursors
32. Interleukin-1 (IL-1) stimulates osteoclast formation in vitro by inducing IL-6 production
33. Autocrine and paracrine growth regulation of human breast cancer
34. Rat transforming growth factor type 1: structure and relation to epidermal growth factor
35. Parathyroid hormone-related protein purified from a human lung cancer cell line
36. Incidence of PTH-rP production by breast carcinoma: immunohistochemical survey of 99 patients
37. Induction of parathyroid hormone-related protein mRNA expression in human lymphocytes by a phorbol ester
38. Immune cells and bone
39. Bone destruction and hypercalcaemia in plasma cell myeloma
40. Collagen and collagen derived fragments are chemotactic for tumor cells
41. Bone resorbing activity in supernatants from lymphoid cell lines
42. The hypercalcaemia of malignancy: pathogenesis and management
43. Evidence for the secretion of an osteoclast stimulating factor in myeloma
44. Selective release of active human TGF beta 1 from its recombinant inactive precursor by isolated osteoclasts
45. Partial characterization of a bone derived chemotactic factor for tumor cells
46. Chemotactic responses of tumour cells to products of resorbing bone
47. The distribution of secondary growths in cancer of the breast
48. Immunological detection and quantification of alpha-transforming growth factor in human breast carcinoma cells
49. Transforming growth factor beta inhibits bone resorption in fetal rat long bone cultures
50. Breast cancer osteolysis, bone metastases, and anti-osteolytic effect of aspirin
51. High extracellular calcium increases the production of a parathyroid hormone-like activity by cultured Leydig tumor cells associated with humoral hypercalcaemia
52. Stimulation of tumor necrosis factor released from monocytic cells by the A375 human melanoma via granulocyte-macrophage colony stimulating factor
53. Increased production of tumor necrosis factor by immune cells in a model of the humoral hypercalcaemia of malignancy
54. Presence of alpha TGF mRNA in human breast cancer cell lines and in human breast carcinomas
55. Identification of a mRNA fraction in human prostatic cancer cells coding for a novel osteoblast-stimulating factor
56. Biochemical evaluation of patients with cancer-associated hypercalcaemia: evidence for humoral and nonhumoral groups
57. N-terminal amino acid sequence of two novel tumor-derived adenylate cyclase-stimulating proteins: identification of parathyroid hormone-like parathyroid hormone-unlike domains
58. Recombinant human transforming growth factor alpha stimulates the formation of osteoclast-like cells in long term human marrow cultures
59. Actions of growth factors on plasma calcium
60. Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption
61. Osteoblasts mediate interleukin-1 stimulation of bone resorption by rat osteoclasts
62. Estrogens and anti-estrogens stimulate release of bone resorbing activity by cultured human breast cancer cells
63. Autocrine growth stimulation of the MCF-7 breast cancer cells by the estrogen-regulated 52kD protein
64. Oestrogen regulates cathepsin D mRNA levels in oestrogen responsive human breast cancer cells
65. The potential role of procathepsin D secreted by breast cancer cells in bone resorption
66. Effects of a synthetic peptide of a parathyroid hormone-related protein on calcium homeostasis, renal tubular calcium reabsorption and bone metabolism
67. Inorganic phosphate inhibits osteoclast formation and the activity of mature osteoclasts
68. Human transforming growth factor (TGFa) causes marked hypercalcaemia in mice and is synergistic with low-dose parathyroid hormone-related protein
69. Hypercalcaemia in a human tumor is due to tumor necrosis factor production by host immune cells
70. The celullar basis of the site-specific tumor metastasis